102 related articles for article (PubMed ID: 6539868)
1. Lymphocytapheresis in chronic progressive multiple sclerosis: immunologic and clinical effects.
Hauser SL; Fosburg M; Kevy SV; Weiner HL
Neurology; 1984 Jul; 34(7):922-6. PubMed ID: 6539868
[TBL] [Abstract][Full Text] [Related]
2. Lymphocytapheresis therapy in multiple sclerosis, a preliminary study.
Medaer R; Eeckhout C; Gautama K; Vermijlen C
Acta Neurol Scand; 1984 Aug; 70(2):111-5. PubMed ID: 6485745
[TBL] [Abstract][Full Text] [Related]
3. Lymphocytapheresis in chronic progressive multiple sclerosis: results of a preliminary trial.
Rose J; Klein H; Greenstein J; McFarlin D; Gerber L; McFarland H
Ann Neurol; 1983 Nov; 14(5):593-4. PubMed ID: 6651245
[No Abstract] [Full Text] [Related]
4. Plasma exchange (PE) and lymphocytapheresis (LCA) in multiple sclerosis (MS).
Höcker P; Stellamor V; Summer K; Mann M
Int J Artif Organs; 1984 Jan; 7(1):39-42. PubMed ID: 6698632
[TBL] [Abstract][Full Text] [Related]
5. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
Hauser SL; Fosburg M; Kevy S; Weiner HL
Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of multiple sclerosis with lymphocytapheresis using a leukocyte adsorption column].
Sato T; Imamura N; Nozaki K; Ishigaki Y
Nihon Rinsho; 1994 Nov; 52(11):3032-7. PubMed ID: 7996706
[TBL] [Abstract][Full Text] [Related]
7. [The dynamics of immunological indicators in the treatment of patients with multiple sclerosis with prednisolone combined with plasmapheresis].
Neretin VIa; Gannushkina IV; Zhirnova IG; Sapfirova VA; Kir'iakov VA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(2):17-21. PubMed ID: 3259769
[TBL] [Abstract][Full Text] [Related]
8. [Lymphocyte subpopulations in multiple sclerosis (MS). A contribution].
Nuccetelli F; Assetta M; Tartaro A; Di Muzio A; Nanni Costa E; Anichini M; Gambi D
Minerva Med; 1989 Mar; 80(3):189-93. PubMed ID: 2654756
[TBL] [Abstract][Full Text] [Related]
9. Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression alone.
Tindall RS; Walker JE; Ehle AL; Near L; Rollins J; Becker D
Neurology; 1982 Jul; 32(7):739-43. PubMed ID: 7201110
[TBL] [Abstract][Full Text] [Related]
10. Plasmapheresis in multiple sclerosis: preliminary study.
Weiner HL; Dawson DM
Neurology; 1980 Oct; 30(10):1029-33. PubMed ID: 7191492
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin G immunosuppression of multiple sclerosis. Suppression of all three major lymphocyte subsets.
Tenser RB; Hay KA; Aberg JA
Arch Neurol; 1993 Apr; 50(4):417-20. PubMed ID: 8460964
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive effects of isoprinosine in man: a comparison to chlorambucil effects in multiple sclerosis.
Pompidou A; Rancurel G; Delsaux MC; Meunier C; Telvi L; Cour V; Buge A
Cancer Detect Prev Suppl; 1987; 1():377-83. PubMed ID: 2446758
[TBL] [Abstract][Full Text] [Related]
13. [The effect of lymphocytapheresis on multiple sclerosis].
Munakata R; Utsugisawa K; Nagane Y; Ukitsu M; Tohgi H
No To Shinkei; 1999 Mar; 51(3):235-9. PubMed ID: 10226287
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cell activity in patients with multiple sclerosis: interferon and plasmapheresis.
Uchida A; Maida EM; Lenzhofer R; Micksche M
Immunobiology; 1982 Feb; 160(5):392-402. PubMed ID: 6175561
[TBL] [Abstract][Full Text] [Related]
15. Persistence of antibrain antibodies in cerebrospinal fluid during plasmapheresis for multiple sclerosis.
Ryberg B; Pirskanen R
Br Med J (Clin Res Ed); 1985 Sep; 291(6499):850-1. PubMed ID: 2996688
[TBL] [Abstract][Full Text] [Related]
16. Plasmapheresis in multiple sclerosis: preliminary findings.
Dau PC; Petajan JH; Johnson KP; Panitch HS; Bornstein MB
Neurology; 1980 Oct; 30(10):1023-8. PubMed ID: 6448360
[TBL] [Abstract][Full Text] [Related]
17. Relapse of multiple sclerosis following acute allergic reactions to plasma during plasmapheresis.
Wirguin I; Shinar E; Abramsky O
J Neurol; 1989 Jan; 236(1):62-3. PubMed ID: 2915232
[TBL] [Abstract][Full Text] [Related]
18. [Lymphocyto-plasmapheresis for relapsing multiple sclerosis].
Jyoichi T; Kamegai M; Noda Y; Shimojo S; Miyahara T
Rinsho Shinkeigaku; 1986 Sep; 26(9):907-9. PubMed ID: 3791770
[No Abstract] [Full Text] [Related]
19. Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody.
Morimoto C; Hafler DA; Weiner HL; Letvin NL; Hagan M; Daley J; Schlossman SF
N Engl J Med; 1987 Jan; 316(2):67-72. PubMed ID: 2946956
[TBL] [Abstract][Full Text] [Related]
20. Long-term lymphocytapheresis therapy in multiple sclerosis. Preliminary observations.
Maida E; Höcker P; Mann E
Eur Neurol; 1986; 25(3):225-32. PubMed ID: 3516705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
